CGCABLE
834639
KLT
831689
DAYU BIOLOGICAL
871970
Fujian Superpipe
300198
WuHan Hvsen Biotechnology
300871
CN Stock MarketDetailed Quotes
301207 Hualan Biological Vaccine Inc.
- 17.29
- +0.03+0.17%
Market Closed Mar 26 15:00 CST
10.39BMarket Cap20.88P/E (TTM)
17.39High17.14Low19.78KlotVolume17.17Open17.26Pre Close34.18MTurnover1.40%Turnover Ratio12.08P/E (Static)601.03MShares24.6052wk High1.71P/B2.45BFloat Cap15.4252wk Low20.71Limit Up141.65MShs Float52.25Historical High13.81Limit Down1.45%Amplitude15.42Historical Low0.60Dividend TTM17.28Avg Price8.97KlotAsk3.47%Div YieldTTM100Lot Size10.28KlotBid
Hualan Biological Vaccine Inc. News
Hualan Vaccine: Huatai United Securities Co., Ltd. report on Hualan Biovaccine Co., Ltd.\'s continuous supervision period 2025 training
Hualan Vaccine: Announcement on Continuing to Use Some Idle Raised Funds for Cash Management
Hualan Vaccine: Announcement of Resolutions of the 10th Meeting of the 2nd Supervisory Committee
Hualan Vaccine: Huatai United Securities Co., Ltd.\'s verification opinion on Hualan Biovaccine Co., Ltd. continuing to use some idle funds raised for cash management
Hualan Vaccine: Announcement of Resolutions of the 12th Meeting of the 2nd Board of Directors
Hualan Vaccine: 2024 performance forecast
Hualan Vaccine: Announcement of Resolutions of the 11th Meeting of the 2nd Board of Directors
Hualan Vaccine: Announcement on the resignation of the company\'s board secretary and financial director and the appointment of the director and general manager to act as board secretary and financial director
Hualan Vaccine: Report for the third quarter of 2024
Hualan Vaccine: Huatai United Securities Co., Ltd.\'s 2024 semi-annual follow-up report on Hualan Biovaccine Co., Ltd.
Hualan Vaccine: 2024-048 Announcement on completion of share repurchase implementation and share changes
Hualan Vaccine: Progress Announcement on the Repurchase of the Company\'s Shares
Hualan Vaccine: Announcement of Board Resolutions
Hualan Vaccine: 2024 Semi-Annual Report
Hualan Vaccine: Summary table on the use of non-operating funds and other related financial transactions
Hualan Vaccine: 2024 Semi-Annual Report Summary
Hualan Vaccine: Special Report on the Storage and Use of Raised Funds for the 2024 Semi-Annual Period
Hualan Vaccine: Announcement of Supervisory Committee Resolutions
Hualan Biological Vaccine Inc.: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Hualan Biological Vaccine Inc.: Legal Opinion of Anhui Chengyi Law Firm on Holding the First Extraordinary Shareholders' Meeting of Hualan Vaccine in 2024